Page last updated: 2024-08-05 12:25:59

homodetic cyclic peptide

A homodetic cyclic peptide is a cyclic peptide in which the ring consists solely of amino-acid residues in peptide linkages.

ChEBI ID: 24613

Members (19)

MemberDefinitionRole
alisporivirAlisporivir
aminocandinA member of the family of echinocandins that shows broad-spectrum in vitro activity against Aspergillus and Candida spp.aminocandin
astressinA 30-membered homodetic cyclic peptide comprising the sequence D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 cyclised by an amide bridge, formed by condensation of the side-chain carboxy group of the Glu residue at position 19 and the side-chain amino group of the Lys residue at position 22.astressin
baci-imA homodetic cyclic peptide consisting of (4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid attached head-to-tail to L-leucyl,D-glutamyl, L-lysyl, D-ornityl, L-isoleucyl, D-phenylalanyl, L-histidyl. D-aspartyl and L-asparaginyl residues coupled in sequence and cyclised by condensation of the side-chain amino group of the L-lysyl residue with the C-terminal carboxylic acid group. It is the major component of bacitracin.bacitracin A zwitterion; bacitracin A
cyclo(leucyl-prolyl)A homodetic cyclic peptide composed from leucyl and prolyl residues.cyclo(L-Leu-L-Pro)
cyclosporineA cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.cyclosporin A
eptifibatideA synthetic homodetic cyclic peptide comprising N(alpha)-(3-sulfanylpropanoyl)homoarginyl, glycyl, aspartyl, tryptophyl, prolyl and cysteinamide residues connected in sequence and cyclised via a disulfide bond. Derived from a protein found in the venom of the southeastern pygmy rattlesnake, Sistrurus miliarus barbouri, eptifibatide is an anti-coagulant that inhibits platelet aggregation by selectively blocking the platelet glycoprotein IIb/IIIa receptor, so preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands. It is used in the management of unstable angina and in patients undergoing coronary angioplasty and stenting procedures.eptifibatide
gramicidin sgramicidin S
hc toxinA homodetic cyclic tetrapeptide made up from L-alanyl, D-alanyl, L-prolyl and 2-amino-8-oxo-9,10-epoxydecanoyl residues.HC toxin
histidyl-proline diketopiperazineA homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH).cyclo(L-His-L-Pro)
lugduninA thiazolidine-containing homodetic cyclic peptide that is isolated from human nasal bacteria. Exhibits bactericidal activity against many major pathogens including methicillin-resistant Staphylococcus aureus (MRSA).lugdunin
maculosinA homodetic cyclic peptide that is a dipeptide composed of L-proline and L-tyrosine joined by peptide linkages.maculosin
pasireotideA six-membered homodetic cyclic peptide composed from L-phenylglycyl, D-tryptophyl, L-lysyl, O-benzyl-L-tyrosyl, L-phenylalanyl and modified L-hydroxyproline residues joined in sequence. A somatostatin analogue with pharmacologic properties mimicking those of the natural hormone somatostatin; used (as its diaspartate salt) for treatment of Cushing's disease.pasireotide
phallacidinA homodetic bicyclic heptapeptide having a sulfide bridge.phallacidin
phalloidineA homodetic bicyclic heptapeptide having a sulfide bridge.phalloidin
sdz psc 833SDZ PSC 833
trapoxin aA homodetic cyclic tetrapeptide constructed from L-phenylalanyl (x2), D-pipecolinyl and L-2-amino-8-oxo-9,10-epoxydecanoyl residues.trapoxin A
tyrocidineA homodetic cyclic decapeptide consisting of D-Phe, L-Pro, L-Phe, D-Phe, L-Asn, L-Gln, L-Tyr, L-Val, L-Orn, and L-Leu residues coupled in sequence and cyclised head-to-tail.tyrocidine A
voclosporinvoclosporin

Research

Studies (4,149)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990413 (9.95)18.7374
1990's816 (19.67)18.2507
2000's1,558 (37.55)29.6817
2010's1,105 (26.63)24.3611
2020's257 (6.19)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials389 (8.93%)5.53%
Reviews426 (9.78%)6.00%
Case Studies152 (3.49%)4.05%
Observational3 (0.07%)0.25%
Other3,387 (77.74%)84.16%